Nikolaos Syrigos
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
- Cancer-related Molecular Pathways 4
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 4
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
-
- Chronic Lymphocytic Leukemia Research 4
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- Ηλίας ΚοττέαςGeorgia GomatouIoannis VathiotisIoannis P. TrontzasAndriani CharpidouIoannis GkiozosCheng FangJun Li
- Journals
- Oncogene (1 paper)International Journal of Molecular Sciences (3 papers)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- GreeceUnited StatesChina
In The Last Decade
Nikolaos Syrigos
54 papers receiving 589 citations
Peers
Comparison fields: 5 of 91
- Oncology 279
- Health Informatics 10
- Cancer Research 91
- Pulmonary and Respiratory Medicine 190
- Immunology 76
Countries citing papers authored by Nikolaos Syrigos
This map shows the geographic impact of Nikolaos Syrigos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaos Syrigos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaos Syrigos more than expected).
Fields of papers citing papers by Nikolaos Syrigos
This network shows the impact of papers produced by Nikolaos Syrigos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaos Syrigos. The network helps show where Nikolaos Syrigos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nikolaos Syrigos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 11 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 20 | |
| 11 | 2024 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 77 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 7 | |
| 19 | 2022 | 61 | |
| 20 | 2019 | 18 |
About Nikolaos Syrigos
Nikolaos Syrigos is a scholar working on Internal Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 599 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), COVID-19 Clinical Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Oncology (279 citations), Health Informatics (10 citations) and Cancer Research (91 citations). Nikolaos Syrigos has collaborated with scholars based in Greece, United States and China. Frequent co-authors include Ηλίας Κοττέας, Georgia Gomatou, Ioannis Vathiotis, Ioannis P. Trontzas, Andriani Charpidou, Ioannis Gkiozos, Cheng Fang, Jun Li, Edward Chu and John C. Schmitz. Their work appears in journals such as Oncogene, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.